Tamara Pilishvili

Best Publications

• Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

  Cynthia G. Whitney;Monica M. Farley;James Hadler;Lee H. Harrison

  2790
  Citations

• Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.

  Stephanie Bialek;Ryan Gierke;Michelle Hughes;Lucy A. McNamara

  1709
  Citations

• Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

  Tamara Pilishvili;Catherine Lexau;Monica M. Farley;Monica M. Farley;James Hadler

  1589
  Citations

• Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

  Almea Matanock;Grace Lee;Ryan Gierke;Miwako Kobayashi

  662
  Citations

• Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.

  Unknown

  644
  Citations

• Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

  Matthew R Moore;Robert E Gertz;Robyn L Woodbury;Genevieve A Barkocy-Gallagher

  613
  Citations

• Surveillance of Vaccination Coverage among Adult Populations — United States, 2015

  Walter W. Williams;Peng-Jun Lu;Alissa O’Halloran;Alissa O’Halloran;David K. Kim

  484
  Citations

• Postvaccine Genetic Structure of Streptococcus pneumoniae Serotype 19A from Children in the United States

  Rekha Pai;Matthew R. Moore;Tamara Pilishvili;Robert E. Gertz

  418
  Citations

• Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

  Unknown

  328
  Citations

• Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.

  Srinivas Nanduri;Tamara Pilishvili;Gordana Derado;Minn Minn Soe

  324
  Citations

• Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  Miwako Kobayashi;Nancy M Bennett;Ryan Gierke;Olivia Almendares

  252
  Citations

• Noninfluenza vaccination coverage among adults - United States, 2012.

  Walter W. Williams;Peng-Jun Lu;Alissa O’Halloran;Carolyn B. Bridges

  250
  Citations

• Vaccination coverage among adults, excluding influenza vaccination - United States, 2013.

  Walter W Williams;Peng-Jun Lu;Alissa O'Halloran;Carolyn B Bridges

  237
  Citations

• Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

  Unknown

  231
  Citations

• Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  Nancy M. Bennett;Tamara Pilishvili;Cynthia G. Whitney;Matthew Moore

  224
  Citations

• Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.

  Tamara Pilishvili;Katherine E. Fleming-Dutra;Jennifer L. Farrar;Ryan Gierke

  208
  Citations

• Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

  Unknown

  185
  Citations

• Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C

  In H. Park;Matthew R. Moore;John J. Treanor;Stephen I. Pelton

  185
  Citations

• Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023

  Unknown

  143
  Citations

• PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007.

  Maria da Gloria Carvalho;Fabiana C. Pimenta;Robert E. Gertz;Hari Har Joshi

  136
  Citations